Evidence map›Paper›PMID 40011469›Full record

ArticleNature communications2025

CD301b

Naoya Tatsumi, Jihad El-Fenej, Alejandro Davila-Pagan, Yosuke Kumamoto

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Thymic Dendritic Cells Revisited.Immunological reviews · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. The role of IL-2 in type 2 immunity.Frontiers in immunology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Naoya TatsumiCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ, USA.ORCID http://orcid.org/0000-0002-8277-0660
Jihad El-FenejCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ, USA.
Alejandro Davila-PaganCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ, USA.
Yosuke KumamotoCenter for Immunity and Inflammation, Rutgers New Jersey Medical School, Newark, NJ, USA. yosuke.kumamoto@rutgers.edu.ORCID http://orcid.org/0000-0001-9369-4934

Funding

Regulation of Th2 differentiation by skin-resident dendritic cellsR01AI132576 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI YOSUKE KUMAMOTO · 2017 to 2026
$3.8M
Mechanism of cDC2 subset differentiation in peripheral organsR01AI165622 · NIAID · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI YOSUKE KUMAMOTO · 2023 to 2026
$2.9M
Role of cDC2 subsets in host protection and CD4T cell responses in melanomaR21CA259541 · NCI · RBHS-NEW JERSEY MEDICAL SCHOOL · PI KUMAMOTO, YOSUKE · 2021 to 2022
$388k
NCI NIH HHS R21 CA259541NIAID NIH HHS R01 AI132576NIAID NIH HHS R01 AI165622U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R21CA259541U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI132576U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) R01AI165622
6 · The paper itself

Abstract

T helper (Th) cell differentiation is fundamental to functional adaptive immunity. Different subsets of dendritic cells (DC) preferentially induce different types of Th cells, but the DC-derived mechanism for Th type 2 (Th2) differentiation is not fully understood. Here, we show that in mice, CD301b

Indexed as

CD4-Positive T-LymphocytesCell DifferentiationDendritic CellsInterleukin-2Lectins, C-TypeTh2 CellsAnimalsCD40 AntigensInterleukin-2 Receptor alpha SubunitMiceMice, Inbred C57BLMice, KnockoutSignal TransductionCD40 AntigensInterleukin-2Interleukin-2 Receptor alpha SubunitLectins, C-Type

Identifiers

PMID40011469
PMCPMC11865452

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.